Search Results

There are 2840 results for: content related to: Toward Correlation in In Vivo and In Vitro Nanotoxicology Studies

  1. Recommendations for Nanomedicine Human Subjects Research Oversight: An Evolutionary Approach for an Emerging Field

    The Journal of Law, Medicine & Ethics

    Volume 40, Issue 4, Winter 2012, Pages: 716–750, Leili Fatehi, Susan M. Wolf, Jeffrey McCullough, Ralph Hall, Frances Lawrenz, Jeffrey P. Kahn, Cortney Jones, Stephen A. Campbell, Rebecca S. Dresser, Arthur G. Erdman, Christy L. Haynes, Robert A. Hoerr, Linda F. Hogle, Moira A. Keane, George Khushf, Nancy M. P. King, Efrosini Kokkoli, Gary Marchant, Andrew D. Maynard, Martin Philbert, Gurumurthy Ramachandran, Ronald A. Siegel and Samuel Wickline

    Version of Record online : 3 JAN 2013, DOI: 10.1111/j.1748-720X.2012.00703.x

  2. Tumor-Penetrating Nanotherapeutics Loading a Near-Infrared Probe Inhibit Growth and Metastasis of Breast Cancer

    Advanced Functional Materials

    Volume 25, Issue 19, May 20, 2015, Pages: 2831–2839, Xinyu He, Xiaoyue Bao, Haiqiang Cao, Zhiwen Zhang, Qi Yin, Wangwen Gu, Lingli Chen, Haijun Yu and Yaping Li

    Version of Record online : 8 APR 2015, DOI: 10.1002/adfm.201500772

  3. Targeted Treatment of Cancer with Nanotherapeutics Based on Mesoporous Silica Nanoparticles


    Volume 80, Issue 1, January 2015, Pages: 26–36, Dr. Nikola Ž. Knežević and Dr. Jean-Olivier Durand

    Version of Record online : 19 JAN 2015, DOI: 10.1002/cplu.201402369

  4. Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma

    Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

    Aniket S. Wadajkar, Jimena G. Dancy, David S. Hersh, Pavlos Anastasiadis, Nhan L. Tran, Graeme F. Woodworth, Jeffrey A. Winkles and Anthony J. Kim

    Version of Record online : 4 NOV 2016, DOI: 10.1002/wnan.1439

  5. Handling Worker and Third-Party Exposures to Nanotherapeutics During Clinical Trials

    The Journal of Law, Medicine & Ethics

    Volume 40, Issue 4, Winter 2012, Pages: 856–864, Gurumurthy Ramachandran, John Howard, Andrew Maynard and Martin Philbert

    Version of Record online : 3 JAN 2013, DOI: 10.1111/j.1748-720X.2012.00714.x

  6. What Is Unique About Nanomedicine? The Significance of the Mesoscale

    The Journal of Law, Medicine & Ethics

    Volume 40, Issue 4, Winter 2012, Pages: 780–794, George Khushf and Ronald A. Siegel

    Version of Record online : 3 JAN 2013, DOI: 10.1111/j.1748-720X.2012.00706.x

  7. Concepts of Risk in Nanomedicine Research

    The Journal of Law, Medicine & Ethics

    Volume 40, Issue 4, Winter 2012, Pages: 809–822, Linda F. Hogle

    Version of Record online : 3 JAN 2013, DOI: 10.1111/j.1748-720X.2012.00709.x

  8. A Portrait of Nanomedicine and Its Bioethical Implications

    The Journal of Law, Medicine & Ethics

    Volume 40, Issue 4, Winter 2012, Pages: 763–779, Rebecca M. Hall, Tong Sun and Mauro Ferrari

    Version of Record online : 3 JAN 2013, DOI: 10.1111/j.1748-720X.2012.00705.x

  9. Reality Check for Nanomaterial-Mediated Therapy with 3D Biomimetic Culture Systems

    Advanced Functional Materials

    Volume 26, Issue 23, June 20, 2016, Pages: 4046–4065, Chor Yong Tay, Madaswamy S. Muthu, Sing Ling Chia, Kim Truc Nguyen, Si-Shen Feng and David Tai Leong

    Version of Record online : 18 APR 2016, DOI: 10.1002/adfm.201600476

  10. An Empirical Examination of the Current State of Publically Available Nanotechnology Guidance Materials

    The Journal of Law, Medicine & Ethics

    Volume 40, Issue 4, Winter 2012, Pages: 751–762, Laura Fleege and Frances Lawrenz

    Version of Record online : 3 JAN 2013, DOI: 10.1111/j.1748-720X.2012.00704.x

  11. Clinical Nanomedicine: A Solution to the Chemotherapy Conundrum in Pediatric Leukemia Therapy

    Clinical Pharmacology & Therapeutics

    Volume 95, Issue 2, February 2014, Pages: 168–178, V Krishnan and A K Rajasekaran

    Version of Record online : 5 SEP 2013, DOI: 10.1038/clpt.2013.174

  12. Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor-targeted drug delivery vectors

    Drug Development Research

    Volume 67, Issue 1, January 2006, Pages: 47–54, Giulio F. Paciotti, David G.I. Kingston and Lawrence Tamarkin

    Version of Record online : 11 MAY 2006, DOI: 10.1002/ddr.20066

  13. Development of Novel Tumor-Targeted Theranostic Nanoparticles Activated by Membrane-Type Matrix Metalloproteinases for Combined Cancer Magnetic Resonance Imaging and Therapy


    Volume 10, Issue 3, February 12, 2014, Pages: 566–575, Celina Ansari, Grigory A. Tikhomirov, Su Hyun Hong, Robert A. Falconer, Paul M. Loadman, Jason H. Gill, Rosalinda Castaneda, Florette K. Hazard, Ling Tong, Olga D. Lenkov, Dean W. Felsher, Jianghong Rao and Heike E. Daldrup-Link

    Version of Record online : 27 AUG 2013, DOI: 10.1002/smll.201301456

  14. Prudent Precaution in Clinical Trials of Nanomedicines

    The Journal of Law, Medicine & Ethics

    Volume 40, Issue 4, Winter 2012, Pages: 831–840, Gary E. Marchant and Rachel A. Lindor

    Version of Record online : 3 JAN 2013, DOI: 10.1111/j.1748-720X.2012.00711.x

  15. You have free access to this content
    Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications

    Journal of Internal Medicine

    Volume 276, Issue 6, December 2014, Pages: 579–617, R. M. Kannan, E. Nance, S. Kannan and D. A. Tomalia

    Version of Record online : 31 JUL 2014, DOI: 10.1111/joim.12280

  16. Destination Known: Targeted Drug Delivery in Atherosclerosis and Thrombosis

    Drug Development Research

    Volume 74, Issue 7, November 2013, Pages: 460–471, Erik Westein, Ulrike Flierl, Christoph E. Hagemeyer and Karlheinz Peter

    Version of Record online : 21 OCT 2013, DOI: 10.1002/ddr.21103

  17. Perspectives and potential applications of nanomedicine in breast and prostate cancer

    Medicinal Research Reviews

    Volume 33, Issue 1, January 2013, Pages: 3–32, Yang Liu, Metasebya Solomon and Samuel Achilefu

    Version of Record online : 9 NOV 2010, DOI: 10.1002/med.20233

  18. Emerging In Vitro Models for Safety Screening of High-Volume Production Nanomaterials under Environmentally Relevant Exposure Conditions


    Volume 9, Issue 9-10, May 27, 2013, Pages: 1504–1520, Mustafa Hussain Kathawala, Sijing Xiong, Mark Richards, Kee Woei Ng, Saji George and Say Chye Joachim Loo

    Version of Record online : 28 SEP 2012, DOI: 10.1002/smll.201201452

  19. Development of Therapeutic Polymeric Nanoparticles for the Resolution of Inflammation

    Advanced Healthcare Materials

    Volume 3, Issue 9, September, 2014, Pages: 1448–1456, Suresh Gadde, Orli Even-Or, Nazila Kamaly, Apoorva Hasija, Philippe G. Gagnon, Krishna H. Adusumilli, Andrea Erakovic, Anoop K. Pal, Xue-Qing Zhang, Nagesh Kolishetti, Jinjun Shi, Edward A. Fisher and Omid C. Farokhzad

    Version of Record online : 24 MAR 2014, DOI: 10.1002/adhm.201300688

  20. Engineering red-blood-cell-membrane–coated nanoparticles for broad biomedical applications

    AIChE Journal

    Volume 61, Issue 3, March 2015, Pages: 738–746, Weiwei Gao and Liangfang Zhang

    Version of Record online : 27 JAN 2015, DOI: 10.1002/aic.14735